📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer. (2018)

First Author: Gong C

Attributed to: Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-17-2259

PubMed Identifier: 29420220

Publication URI: http://europepmc.org/abstract/MED/29420220

Type: Journal Article/Review

Volume: 24

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 15

ISSN: 1078-0432